<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The CHA(2)DS(2)-VASc (<z:hpo ids='HP_0001635'>Congestive heart failure</z:hpo>, <z:hpo ids='HP_0000822'>Hypertension</z:hpo>, Age â‰¥75 years, <z:hpo ids='HP_0000819'>Diabetes mellitus</z:hpo>, previous <z:hpo ids='HP_0001297'>Stroke</z:hpo>/<z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> [<z:hpo ids='HP_0002326'>TIA</z:hpo>], <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">Vascular disease</z:e>, Age 65-74 years, and Sex category [female gender]) schema recently has been introduced to complement the CHADS(2) (<z:hpo ids='HP_0001635'>Congestive heart failure</z:hpo>, <z:hpo ids='HP_0000822'>Hypertension</z:hpo>, Age &gt;75 years, <z:hpo ids='HP_0000819'>Diabetes mellitus</z:hpo>, and previous <z:hpo ids='HP_0001297'>stroke</z:hpo> or <z:hpo ids='HP_0002326'>TIA</z:hpo>) score and improve the identification of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) patients at "truly low risk" for <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We tested the predictive ability of the CHA(2)DS(2)-VASc, CHADS(2), and van Walraven risk stratification schemes in a cohort of "lone" AF patients with a 12-year follow-up </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: We conducted a registry-based, observational cohort study of 345 patients initially diagnosed with "lone" AF between 1992 and 2007 </plain></SENT>
<SENT sid="3" pm="."><plain>At baseline, <z:hpo ids='HP_0000001'>all</z:hpo> patients had the CHADS(2) and van Walraven scores of 0, and 262 (75.9%) had a CHA(2)DS(2)-VASc score of 0 </plain></SENT>
<SENT sid="4" pm="."><plain>During follow-up (or within a year prior to <z:hpo ids='HP_0001297'>stroke</z:hpo>), 228 (66.1%), 234 (67.8%), and 150 patients (43.5%) retained the CHADS(2), van Walraven, and CHA(2)DS(2)-VASc scores of 0, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>The overall rate of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> was 0.19 (95% CI: 0.18-0.20) per 100 patient years </plain></SENT>
<SENT sid="6" pm="."><plain>In the multivariable analysis, only the CHA(2)DS(2)-VASc score of 0 was significantly related to the absence of <z:hpo ids='HP_0001297'>stroke</z:hpo> (odds ratio 5.1, 95% CI: 1.5-16.8, P=0.008) </plain></SENT>
<SENT sid="7" pm="."><plain>Only the CHA(2)DS(2)-VASc score had a significant prediction ability (c-statistic 0.72 [0.61-0.84], P=0.031) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The CHA(2)DS(2)-VASc score reliably identified the "lone" AF patients who were at "truly low risk" for <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>, and was the only tested risk stratification scheme with a significant predictive ability for <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> among lone AF patients </plain></SENT>
</text></document>